tarbent
zentiva italia s.r.l. - tapentadol - tapentadol
empressin
orpha-devel handels und vertriebs gmbh - vasopressina - vasopressina
pravastatina sandoz gmbh
sandoz gmbh - pravastatina - pravastatina
paracetamolo pharma bavaria internacional
pharma bavaria internacional (pbi) portugal, unipessoal lda - paracetamolo - paracetamolo
tresuvi
orpha-devel handels und vertriebs gmbh - treprostinil - treprostinil
esmocard
orpha-devel handels und vertriebs gmbh - esmololo - esmololo
vitis vinifera yes pharma
yes pharmaceutical development services gmbh -
skytrofa (previously lonapegsomatropin ascendis pharma)
ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - ormoni ipofisari e ipotalamici e analoghi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - imaging dei radionuclidi - radiofarmaci terapeutici - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.
increxxa
elanco gmbh - tulatromicina - antibatterici per uso sistemico - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. la presenza della malattia nella mandria deve essere stabilita prima del trattamento metafilattico. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. la presenza della malattia nella mandria deve essere stabilita prima del trattamento metafilattico. the product should only be used if pigs are expected to develop the disease within 2–3 days. pecora: trattamento delle prime fasi di pododermatite infettiva (marciume del piede) associata a dichelobacter nodosus virulento che richiede un trattamento sistemico.